The spinal basis of opioid tolerance and physical dependence: Involvement of calcitonin gene-related peptide, substance P, and arachidonic acid-derived metabolites

Peptides

Volumn 26, Issue 8, 2005, Pages 1346-1355

  Trang, Tuan ^a   Quirion, Remi ^b   Jhamandas, Khem ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Calcitonin gene related peptide; Cyclooxygenase; Endocannabinoids; Lipoxygenase; Opioid physical dependence; Opioid tolerance; Substance P

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 5 BROMO 2 (4 FLUOROPHENYL) 3 (4 METHYLSULFONYLPHENYL)THIOPHENE; ANANDAMIDE; ARACHIDONIC ACID; BAICALEIN; BENZOQUINONE DERIVATIVE; CALCITONIN GENE RELATED PEPTIDE; CYCLOOXYGENASE 2 INHIBITOR; DOCEBENONE; ENDOCANNABINOID; IBUPROFEN; KETOROLAC; LIPOXYGENASE; LIPOXYGENASE INHIBITOR; MORPHINE; NIMESULIDE; NOLPITANTIUM; OLCEGEPANT; OPIATE; OPIATE ANTAGONIST; PROSTAGLANDIN; RECEPTOR BLOCKING AGENT; SUBSTANCE P;

ADAPTATION; ANALGESIA; CONFERENCE PAPER; DOWNSTREAM PROCESSING; DRUG DEPENDENCE; DRUG TOLERANCE; GENE FUNCTION; HUMAN; METABOLISM; NONHUMAN; PAIN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANALGESICS, OPIOID; ANIMALS; ARACHIDONIC ACIDS; CALCITONIN GENE-RELATED PEPTIDE; DRUG TOLERANCE; HUMANS; MODELS, BIOLOGICAL; PAIN MEASUREMENT; SPINAL CORD; SUBSTANCE P;

EID: 22544435496     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2005.03.031     Document Type: Conference Paper

References (153)

1. J. Ahluwalia, L. Urban, S. Bevan, M. Capogna, and I. Nagy Cannabinoid 1 receptors are expressed by nerve growth factor- and glial cell-derived neurotrophic factor-responsive primary sensory neurones Neuroscience 110 2002 747 753
2. J. Ahluwalia, L. Urban, S. Bevan, and I. Nagy Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro Eur J Neurosci 17 2003 2611 2618
3. J. Ahluwalia, L. Urban, M. Capogna, S. Bevan, and I. Nagy Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons Neuroscience 100 2000 685 688
4. S. Belanger, W. Ma, J.G. Chabot, and R. Quirion Expression of calcitonin gene-related peptide, substance P and protein kinase C in cultured dorsal root ganglion neurons following chronic exposure to mu, delta and kappa opiates Neuroscience 115 2002 441 453
5. L. Bergstrom, T. Sakurada, and L. Terenius Substance P levels in various regions of the rat central nervous system after acute and chronic morphine treatment Life Sci 35 1984 2375 2382
6. G. Biella, C. Panara, A. Pecile, and M.L. Sotgiu Facilitatory role of calcitonin gene-related peptide (CGRP) on excitation induced by substance P (SP) and noxious stimuli in rat spinal dorsal horn neurons. An iontophoretic study in vivo Brain Res 559 1991 352 356
7. H. Bisgaard, and J.K. Kristensen Leukotriene B4 produces hyperalgesia in humans Prostaglandins 30 1985 791 797
8. M. Bouaboula, C. Poinot-Chazel, B. Bourrie, X. Canat, B. Calandra, and M. Rinaldi-Carmona Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1 Biochem J 312 Pt. 2 1995 637 641
9. A. Capasso Further studies on the involvement of the arachidonic acid cascade in the acute dependence produced by mu, kappa and delta opioid agonists in isolated tissues Neuropharmacology 38 1999 871 877
10. A. Capasso, and L. Sorrentino Arachidonic acid and its metabolites are involved in the expression of morphine dependence in guinea-pig isolated ileum Eur J Pharmacol 330 1997 199 204
11. D.L. Cichewicz, Z.L. Martin, F.L. Smith, and S.P. Welch Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification J Pharmacol Exp Ther 289 1999 859 867
12. S.M. Crain, and K.F. Shen Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioid analgesia Brain Res 888 2001 75 82
13. R.A. Cridland, and J.L. Henry Intrathecal administration of CGRP in the rat attenuates a facilitation of the tail flick reflex induced by either substance P or noxious cutaneous stimulation Neurosci Lett 102 1989 241 246
14. A.I. Del, M. Navarro, A. Bilbao, B. Ferrer, D. Piomelli, and D.F. Rodriguez Attenuation of spontaneous opiate withdrawal in mice by the anandamide transport inhibitor AM404 Eur J Pharmacol 454 2002 103 104
15. W.A. Devane, L. Hanus, A. Breuer, R.G. Pertwee, L.A. Stevenson, and G. Griffin Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 258 1992 1946 1949
16. D.M. Dirig, and T.L. Yaksh In vitro prostanoid release from spinal cord following peripheral inflammation: effects of substance P, NMDA and capsaicin Br J Pharmacol 126 1999 1333 1340
17. L.F. Donaldson, A.J. Harmar, D.S. McQueen, and J.R. Seckl Increased expression of preprotachykinin, calcitonin gene-related peptide, but not vasoactive intestinal peptide messenger RNA in dorsal root ganglia during the development of adjuvant monoarthritis in the rat Brain Res Mol Brain Res 16 1992 143 149
18. H. Doods, G. Hallermayer, D. Wu, M. Entzeroth, K. Rudolf, and W. Engel Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist Br J Pharmacol 129 2000 420 423
19. S. Dunbar, and T.L. Yaksh Effect of spinal infusion of l-NAME, a nitric oxide synthase inhibitor, on spinal tolerance and dependence induced by chronic intrathecal morphine in the rat Neurosci Lett. 207 1996 33 36
20. S.A. Dunbar, I.G. Karamov, and H. Buerkle The effect of spinal ibuprofen on opioid withdrawal in the rat Anesth Analg 91 2000 417 422
21. M. Egertova, D.K. Giang, B.F. Cravatt, and M.R. Elphick A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain Proc R Soc Lond B Biol Sci 265 1998 2081 2085
22. W.P. Farquhar-Smith, M. Egertova, E.J. Bradbury, S.B. McMahon, A.S. Rice, and M.R. Elphick Cannabinoid CB(1) receptor expression in rat spinal cord Mol Cell Neurosci 15 2000 510 521
23. C.C. Felder, K.E. Joyce, E.M. Briley, J. Mansouri, K. Mackie, and O. Blond Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors Mol Pharmacol 48 1995 443 450
24. M.T. Galeazza, M.G. Garry, H.J. Yost, K.A. Strait, K.M. Hargreaves, and V.S. Seybold Plasticity in the synthesis and storage of substance P and calcitonin gene-related peptide in primary afferent neurons during peripheral inflammation Neuroscience 66 1995 443 458
25. L.R. Gardell, R. Wang, S.E. Burgess, M.H. Ossipov, T.W. Vanderah, and T.P. Malan Jr Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers J Neurosci 22 2002 6747 6755
26. I.L. Gibbins, J.B. Furness, and M. Costa Pathway-specific patterns of the co-existence of substance P, calcitonin gene-related peptide, cholecystokinin and dynorphin in neurons of the dorsal root ganglia of the guinea-pig Cell Tissue Res 248 1987 417 437
27. I.L. Gibbins, and J.L. Morris Co-existence of neuropeptides in sympathetic, cranial autonomic and sensory neurons innervating the iris of the guinea-pig J Auton Nerv Syst 21 1987 67 82
28. S.J. Gibson, J.M. Polak, S.R. Bloom, I.M. Sabate, P.M. Mulderry, and M.A. Ghatei Calcitonin gene-related peptide immunoreactivity in the spinal cord of man and of eight other species J Neurosci 4 1984 3101 3111
29. A. Gilbert, C. LeGouill, C. Thompson, G. Pasternak, J. Stankova, and M. Rola-Pleszczynski Expression and modulation of the cysteinyl leukotriene receptor (cysLT1R) in the central nervous system Soc Neurosci Abstr 695 2003 11
30. D.W. Gilroy, A. Tomlinson, and D.A. Willoughby Differential effects of inhibitors of cyclooxygenase (cyclooxygenase 1 and cyclooxygenase 2) in acute inflammation Eur J Pharmacol 355 1998 211 217
31. A. Giuffrida, L.H. Parsons, T.M. Kerr, D.F. Rodriguez, M. Navarro, and D. Piomelli Dopamine activation of endogenous cannabinoid signaling in dorsal striatum Nat Neurosci 2 1999 358 363
32. S. Gonzalez, J. Fernandez-Ruiz, V. Sparpaglione, D. Parolaro, and J.A. Ramos Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels Drug Alcohol Depend 66 2002 77 84
33. S. Gonzalez, P.C. Schmid, J. Fernandez-Ruiz, R. Krebsbach, H.H. Schmid, and J.A. Ramos Region-dependent changes in endocannabinoid transmission in the brain of morphine-dependent rats Addict Biol 8 2003 159 166
34. R. Hass, M. Brach, S. Kharbanda, G. Giese, P. Traub, and D. Kufe Inhibition of phorbol ester-induced monocytic differentiation by dexamethasone is associated with down-regulation of c-fos and c-jun (AP-1) J Cell Physiol 149 1991 125 131
35. C. Hay, and J. de Belleroche Carrageenan-induced hyperalgesia is associated with increased cyclo-oxygenase-2 expression in spinal cord Neuroreport 8 1997 1249 1251
36. A.G. Hohmann, E.M. Briley, and M. Herkenham Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord Brain Res 822 1999 17 25
37. A.G. Hohmann, and M. Herkenham Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study Neuroscience 90 1999 923 931
38. A.G. Hohmann, K. Tsou, and J.M. Walker Intrathecal cannabinoid administration suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in rat spinal cord: comparison with morphine Zhongguo Yao Li Xue Bao 20 1999 1132 1136
39. T. Hokfelt, U. Arvidsson, S. Cullheim, D. Millhorn, A.P. Nicholas, and V. Pieribone Multiple messengers in descending serotonin neurons: localization and functional implications J Chem Neuroanat 18 2000 75 86
40. T. Hokfelt, J.O. Kellerth, G. Nilsson, and B. Pernow Substance p: localization in the central nervous system and in some primary sensory neurons Science 190 1975 889 890
41. X.Y. Hua, P. Chen, M. Marsala, and T.L. Yaksh Intrathecal substance P-induced thermal hyperalgesia and spinal release of prostaglandin E2 and amino acids Neuroscience 89 1999 525 534
42. J.L. Hylden, and G.L. Wilcox Pharmacological characterization of substance P-induced nociception in mice: modulation by opioid and noradrenergic agonists at the spinal level J Pharmacol Exp Ther 226 1983 398 404
43. T.M. Jessell, and L.L. Iversen Opiate analgesics inhibit substance P release from rat trigeminal nucleus Nature 268 1977 549 551
44. J.H. Jhamandas, K.H. Harris, T. Petrov, H.Y. Yang, and K.H. Jhamandas Activation of neuropeptide FF neurons in the brainstem nucleus tractus solitarius following cardiovascular challenge and opiate withdrawal J Comp Neurol 402 1998 210 221
45. K.H. Jhamandas, M. Marsala, T. Ibuki, and T.L. Yaksh Spinal amino acid release and precipitated withdrawal in rats chronically infused with spinal morphine J Neurosci 16 1996 2758 2766
46. C. Juaneda, Y. Dumont, and R. Quirion The molecular pharmacology of CGRP and related peptide receptor subtypes Trends Pharmacol Sci 21 2000 432 438
47. I. Kangrga, J.S. Larew, and M. Randic The effects of substance P and calcitonin gene-related peptide on the efflux of endogenous glutamate and aspartate from the rat spinal dorsal horn in vitro Neurosci Lett 108 1990 155 160
48. R.M. Kanner, and K.M. Foley Patterns of narcotic drug use in a cancer pain clinic Ann NY Acad Sci 362 1981 161 172
49. H. Kawajiri, D. Zhuang, N. Qiao, T. Yoshimoto, M. Yamamoto, and S. Iseki Expression of arachidonate 12-lipoxygenase in rat tissues: a possible role in glucagon secretion J Histochem Cytochem 48 2000 1411 1419
50. T. Kirchner, B. Aparicio, D.C. Argentieri, C.Y. Lau, and D.M. Ritchie Effects of tepoxalin, a dual inhibitor of cyclooxygenase/5- lipoxygenase, on events associated with NSAID-induced gastrointestinal inflammation Prostaglandins Leukot Essent Fatty Acids 56 1997 417 423
51. Y. Kuraishi, N. Hirota, Y. Sato, N. Hanashima, H. Takagi, and M. Satoh Stimulus specificity of peripherally evoked substance P release from the rabbit dorsal horn in situ Neuroscience 30 1989 241 250
52. S.B. Lane-Ladd, J. Pineda, V.A. Boundy, T. Pfeuffer, J. Krupinski, and G.K. Aghajanian CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence J Neurosci 17 1997 7890 7901
53. P. Le Greves, F. Nyberg, L. Terenius, and T. Hokfelt Calcitonin gene-related peptide is a potent inhibitor of substance P degradation Eur J Pharmacol 115 1985 309 311
54. C. Ledent, O. Valverde, G. Cossu, F. Petitet, J.F. Aubert, and F. Beslot Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice Science 283 1999 401 404
55. F. Lembeck, K. Folkers, and J. Donnerer Analgesic effect of antagonists of substance P Biochem Biophys Res Commun 103 1981 1318 1321
56. C. Levenes, H. Daniel, P. Soubrie, and F. Crepel Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells J Physiol 510 Pt 3 1998 867 879
57. J.D. Levine, J. Gooding, P. Donatoni, L. Borden, and E.J. Goetzl The role of the polymorphonuclear leukocyte in hyperalgesia J Neurosci 5 1985 3025 3029
58. J.D. Levine, W. Lau, G. Kwiat, and E.J. Goetzl Leukotriene B4 produces hyperalgesia that is dependent on polymorphonuclear leukocytes Science 225 1984 743 745
59. W. Ma, W.H. Zheng, S. Kar, and R. Quirion Morphine treatment induced calcitonin gene-related peptide and substance P increases in cultured dorsal root ganglion neurons Neuroscience 99 2000 529 539
60. W. Ma, W.H. Zheng, K. Powell, K. Jhamandas, and R. Quirion Chronic morphine exposure increases the phosphorylation of MAP kinases and the transcription factor CREB in dorsal root ganglion neurons: an in vitro and in vivo study Eur J Neurosci 14 2001 1091 1104
61. R. Maldonado, D. Girdlestone, and B.P. Roques RP 67580, a selective antagonist of neurokinin-1 receptors, modifies some of the naloxone-precipitated morphine withdrawal signs in rats Neurosci Lett 156 1993 135 140
62. A.B. Malmberg, and T.L. Yaksh Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat J Pharmacol Exp Ther 263 1992 136 146
63. A.B. Malmberg, and T.L. Yaksh Cyclooxygenase inhibition and the spinal release of prostaglandin E2 and amino acids evoked by paw formalin injection: a microdialysis study in unanesthetized rats J Neurosci 15 1995 2768 2776
64. J. Mao, D.D. Price, J. Lu, and D.J. Mayer Antinociceptive tolerance to the mu-opioid agonist DAMGO is dose-dependently reduced by MK-801 in rats Neurosci Lett 250 1998 193 196
65. J. Mao, D.D. Price, and D.J. Mayer Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C J Neurosci 14 1994 2301 2312
66. P.I. Mapp, G. Terenghi, D.A. Walsh, S.T. Chen, S.C. Cruwys, and N. Garrett Monoarthritis in the rat knee induces bilateral and time-dependent changes in substance P and calcitonin gene-related peptide immunoreactivity in the spinal cord Neuroscience 57 1993 1091 1096
67. D. Marriott, G.P. Wilkin, P.R. Coote, and J.N. Wood Eicosanoid synthesis by spinal cord astrocytes is evoked by substance P; possible implications for nociception and pain Adv Prostaglandin Thromboxane Leukot Res 21B 1991 739 741
68. D.R. Marriott, G.P. Wilkin, and J.N. Wood Substance P-induced release of prostaglandins from astrocytes: regional specialisation and correlation with phosphoinositol metabolism J Neurochem 56 1991 259 265
69. H.A. Martin, A.I. Basbaum, E.J. Goetzl, and J.D. Levine Leukotriene B4 decreases the mechanical and thermal thresholds of C-fiber nociceptors in the hairy skin of the rat J Neurophysiol 60 1988 438 445
70. H.A. Martin, A.I. Basbaum, G.C. Kwiat, E.J. Goetzl, and J.D. Levine Leukotriene and prostaglandin sensitization of cutaneous high-threshold C- and A-delta mechanonociceptors in the hairy skin of rat hindlimbs Neuroscience 22 1987 651 659
71. M. Mas-Nieto, B. Pommier, E.T. Tzavara, A. Caneparo, S. Da Nascimento, and G. Le Fur Reduction of opioid dependence by the CB(1) antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction Br J Pharmacol 132 2001 1809 1816
72. P. Massi, A. Vaccani, S. Romorini, and D. Parolaro Comparative characterization in the rat of the interaction between cannabinoids and opiates for their immunosuppressive and analgesic effects J Neuroimmunol 117 2001 116 124
73. L.A. Matsuda, S.J. Lolait, M.J. Brownstein, A.C. Young, and T.I. Bonner Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 346 1990 561 564
74. H. Matsumura, T. Sakurada, A. Hara, S. Sakurada, and K. Kisara Characterization of the hyperalgesic effect induced by intrathecal injection of substance P Neuropharmacology 24 1985 421 426
75. K. Matsumura, Y. Watanabe, K. Imai-Matsumura, M. Connolly, Y. Koyama, and H. Onoe Mapping of prostaglandin E2 binding sites in rat brain using quantitative autoradiography Brain Res 581 1992 292 298
76. H. McQuay Opioids in pain management Lancet 353 1999 2229 2232
77. R. Mechoulam, E. Fride, S. Ben Shabat, U. Meiri, and M. Horowitz Carbachol, an acetylcholine receptor agonist, enhances production in rat aorta of 2-arachidonoyl glycerol, a hypotensive endocannabinoid Eur J Pharmacol 362 1998 R1 R3
78. D.P. Menard, D. van Rossum, S. Kar, F.B. Jolicoeur, K. Jhamandas, and R. Quirion Tolerance to the antinociceptive properties of morphine in the rat spinal cord: alteration of calcitonin gene-related peptide-like immunostaining and receptor binding sites J Pharmacol Exp Ther 273 1995 887 894
79. D.P. Menard, D. van Rossum, S. Kar, and R. Quirion Alteration of calcitonin gene related peptide and its receptor binding sites during the development of tolerance to mu and delta opioids Can J Physiol Pharmacol 73 1995 1089 1095
80. A. Merighi, J.M. Polak, and D.T. Theodosis Ultrastructural visualization of glutamate and aspartate immunoreactivities in the rat dorsal horn, with special reference to the co-localization of glutamate, substance P and calcitonin-gene related peptide Neuroscience 40 1991 67 80
81. N. Michaud, and R. Couture Cardiovascular and behavioural effects induced by naloxone-precipitated morphine withdrawal in rat: characterization with tachykinin antagonists Neuropeptides 37 2003 345 354
82. C.R. Morton, and W.D. Hutchison Release of sensory neuropeptides in the spinal cord: studies with calcitonin gene-related peptide and galanin Neuroscience 31 1989 807 815
83. S. Munro, K.L. Thomas, and M. Abu-Shaar Molecular characterization of a peripheral receptor for cannabinoids Nature 365 1993 61 65
84. K. Murase, P.D. Ryu, and M. Randic Excitatory and inhibitory amino acids and peptide-induced responses in acutely isolated rat spinal dorsal horn neurons Neurosci Lett 103 1989 56 63
85. P. Murtra, A.M. Sheasby, S.P. Hunt, and C. De Felipe Rewarding effects of opiates are absent in mice lacking the receptor for substance P Nature 405 2000 180 183
86. J.I. Nagy, and D. van der Kooy Effects of neonatal capsaicin treatment on nociceptive thresholds in the rat J Neurosci 3 1983 1145 1150
87. M. Navarro, M.R. Carrera, W. Fratta, O. Valverde, G. Cossu, and L. Fattore Functional interaction between opioid and cannabinoid receptors in drug self-administration J Neurosci 21 2001 5344 5350
88. M. Navarro, J. Chowen, A.C. Rocio, A.I. Del, M.A. Villanua, and Y. Martin CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats Neuroreport 9 1998 3397 3402
89. J. Nemeth, Z. Helyes, M. Than, B. Jakab, E. Pinter, and J. Szolcsanyi Concentration-dependent dual effect of anandamide on sensory neuropeptide release from isolated rat tracheae Neurosci Lett 336 2003 89 92
90. E.J. Nestler Under siege: the brain on opiates Neuron 16 1996 897 900
91. I. Nylander, T. Sakurada, P. Le Greves, and L. Terenius Levels of dynorphin peptides, substance P and CGRP in the spinal cord after subchronic administration of morphine in the rat Neuropharmacology 30 1991 1219 1223
92. R. Oku, M. Satoh, N. Fujii, A. Otaka, H. Yajima, and H. Takagi Calcitonin gene-related peptide promotes mechanical nociception by potentiating release of substance P from the spinal dorsal horn in rats Brain Res 403 1987 350 354
93. W.Y. Ong, and K. Mackie A light and electron microscopic study of the CB1 cannabinoid receptor in the primate spinal cord J Neurocytol 28 1999 39 45
94. A.M. Parsons, and V.S. Seybold Calcitonin gene-related peptide induces the formation of second messengers in primary cultures of neonatal rat spinal cord Synapse 26 1997 235 242
95. H.H. Patel, R.M. Fryer, E.R. Gross, R.A. Bundey, A.K. Hsu, and M. Isbell 12-lipoxygenase in opioid-induced delayed cardioprotection: gene array, mass spectrometric, and pharmacological analyses Circ Res 92 2003 676 682
96. M.F. Piercey, P.J. Dobry, L.A. Schroeder, and F.J. Einspahr Behavioral evidence that substance P may be a spinal cord sensory neurotransmitter Brain Res 210 1981 407 412
97. G.M. Pitcher, and J.L. Henry Mediation and modulation by eicosanoids of responses of spinal dorsal horn neurons to glutamate and substance P receptor agonists: results with indomethacin in the rat in vivo Neuroscience 93 1999 1109 1121
98. G.M. Pitcher, and J.L. Henry NSAID-induced cyclooxygenase inhibition differentially depresses long- lasting versus brief synaptically-elicited responses of rat spinal dorsal horn neurons in vivo Pain 82 1999 173 186
99. F.E. Pontieri, P. Monnazzi, A. Scontrini, F.R. Buttarelli, and F.R. Patacchioli Behavioral sensitization to heroin by cannabinoid pretreatment in the rat Eur J Pharmacol 421 2001 R1 R3
100. F.E. Pontieri, P. Monnazzi, A. Scontrini, F.R. Buttarelli, and F.R. Patacchioli Behavioral sensitization to WIN55212.2 in rats pretreated with heroin Brain Res 898 2001 178 180
101. K.J. Powell, A. Hosokawa, A. Bell, M. Sutak, B. Milne, and R. Quirion Comparative effects of cyclo-oxygenase and nitric oxide synthase inhibition on the development and reversal of spinal opioid tolerance Br J Pharmacol 127 1999 631 644
102. K.J. Powell, W. Ma, M. Sutak, H. Doods, R. Quirion, and K. Jhamandas Blockade and reversal of spinal morphine tolerance by peptide and non- peptide calcitonin gene-related peptide receptor antagonists Br J Pharmacol 131 2000 875 884
103. K.J. Powell, R. Quirion, and K. Jhamandas Inhibition of neurokinin-1-substance P receptor and prostanoid activity prevents and reverses the development of morphine tolerance in vivo and the morphine-induced increase in CGRP expression in cultured dorsal root ganglion neurons Eur J Neurosci 18 2003 1572 1583
104. J. Priller, C.A. Haas, M. Reddington, and G.W. Kreutzberg Calcitonin gene-related peptide and ATP induce immediate early gene expression in cultured rat microglial cells Glia 15 1995 447 457
105. J. Priller, C.A. Haas, M. Reddington, and G.W. Kreutzberg Cultured astrocytes express functional receptors for galanin Glia 24 1998 323 328
106. J. Priller, M. Reddington, C.A. Haas, and G.W. Kreutzberg Stimulation of P2Y-purinoceptors on astrocytes results in immediate early gene expression and potentiation of neuropeptide action Neuroscience 85 1998 521 525
107. A. Rackham, and A.W. Ford-Hutchinson Inflammation and pain sensitivity: effects of leukotrienes D4, B4 and prostaglandin E1 in the rat paw Prostaglandins 25 1983 193 203
108. M. Reddington, J. Priller, J. Treichel, C. Haas, and G.W. Kreutzberg Astrocytes and microglia as potential targets for calcitonin gene related peptide in the central nervous system Can J Physiol Pharmacol 73 1995 1047 1049
109. J.D. Richardson, L. Aanonsen, and K.M. Hargreaves Antihyperalgesic effects of spinal cannabinoids Eur J Pharmacol 345 1998 145 153
110. J.D. Richardson, S. Kilo, and K.M. Hargreaves Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors Pain 75 1998 111 119
111. J. Ritchie, G.M. Pitcher, and R.N. Sharif Lipoxygenase inhibition depresses hyperalgesia induced by intrathecal administration of substance P, NMDA and AMPA in the rat Soc Neurosci Abstr 26 2000 1958
112. D.S. Rohde, D.J. Detweiler, and A.I. Basbaum Spinal cord mechanisms of opioid tolerance and dependence: Fos-like immunoreactivity increases in subpopulations of spinal cord neurons during withdrawal [corrected] Neuroscience 72 1996 233 242
113. D.S. Rohde, W.R. McKay, C. Abbadie, and A.I. Basbaum Contribution of sacral spinal cord neurons to the autonomic and somatic consequences of withdrawal from morphine in the rat Brain Res 745 1997 83 95
114. J. Romero, J.J. Fernandez-Ruiz, G. Vela, M. Ruiz-Gayo, J.A. Fuentes, and J.A. Ramos Autoradiographic analysis of cannabinoid receptor binding and cannabinoid agonist-stimulated [35S]GTP gamma S binding in morphine-dependent mice Drug Alcohol Depend 50 1998 241 249
115. D.W. Rowen, J.P. Embrey, C.H. Moore, and S.P. Welch Antisense oligodeoxynucleotides to the kappa1 receptor enhance delta9-THC-induced antinociceptive tolerance Pharmacol Biochem Behav 59 1998 399 404
116. T. Rubino, P. Massi, D. Vigano, D. Fuzio, and D. Parolaro Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndrome Life Sci 66 2000 2213 2219
117. T. Rubino, L. Tizzoni, D. Vigano, P. Massi, and D. Parolaro Modulation of rat brain cannabinoid receptors after chronic morphine treatment Neuroreport 8 1997 3219 3223
118. C. Salio, J. Fischer, M.F. Franzoni, K. Mackie, T. Kaneko, and M. Conrath CB1-cannabinoid and mu-opioid receptor co-localization on postsynaptic target in the rat dorsal horn Neuroreport 12 2001 3689 3692
119. A.M. Salmon, M.I. Damaj, L.M. Marubio, M.P. Epping-Jordan, E. Merlo-Pich, and J.P. Changeux Altered neuroadaptation in opiate dependence and neurogenic inflammatory nociception in alpha CGRP-deficient mice Nat Neurosci 4 2001 357 358
120. K. Seidel, M. Hamza, M. Ates, and H. Guhring Flurbiprofen inhibits capsaicin induced calcitonin gene related peptide release from rat spinal cord via an endocannabinoid dependent mechanism Neurosci Lett 338 2003 99 102
121. V.S. Seybold, K.E. McCarson, P.G. Mermelstein, R.D. Groth, and L.G. Abrahams Calcitonin gene-related peptide regulates expression of neurokinin1 receptors by rat spinal neurons J Neurosci 23 2003 1816 1824
122. M. Shapira, M. Gafni, and Y. Sarne Independence of, and interactions between, cannabinoid and opioid signal transduction pathways in N18TG2 cells Brain Res 806 1998 26 35
123. K.F. Shen, and S.M. Crain Cholera toxin-B subunit blocks excitatory opioid receptor-mediated hyperalgesic effects in mice, thereby unmasking potent opioid analgesia and attenuating opioid tolerance/dependence Brain Res 919 2001 20 30
124. N. Shimoyama, M. Shimoyama, C.E. Inturrisi, and K.J. Elliott Ketamine attenuates and reverses morphine tolerance in rodents Anesthesiology 85 1996 1357 1366
125. P.B. Smith, S.P. Welch, and B.R. Martin Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice J Pharmacol Exp Ther 268 1994 1381 1387
126. M.D. Southall, R.L. Michael, and M.R. Vasko Intrathecal NSAIDS attenuate inflammation-induced neuropeptide release from rat spinal cord slices Pain 78 1998 39 48
127. N. Stella, and D. Piomelli Receptor-dependent formation of endogenous cannabinoids in cortical neurons Eur J Pharmacol 425 2001 189 196
128. N. Stella, P. Schweitzer, and D. Piomelli A second endogenous cannabinoid that modulates long-term potentiation Nature 388 1997 773 778
129. A. Tessler, E. Glazer, R. Artymyshyn, M. Murray, and M.E. Goldberger Recovery of substance P in the cat spinal cord after unilateral lumbosacral deafferentation Brain Res 191 1980 459 470
130. A. Tessler, B.T. Himes, R. Artymyshyn, M. Murray, and M.E. Goldberger Spinal neurons mediate return of substance P following deafferentation of cat spinal cord Brain Res 230 1981 263 281
131. S.N. Thorat, and H.N. Bhargava Evidence for a bidirectional cross-tolerance between morphine and delta 9-tetrahydrocannabinol in mice Eur J Pharmacol 260 1994 5 13
132. G.K. Tiong, T.L. Pierce, and J.E. Olley Sub-chronic exposure to opiates in the rat: effects on brain levels of substance P and calcitonin gene-related peptide during dependence and withdrawal J Neurosci Res 32 1992 569 575
133. T. Trang, J.-G. Chabot, R. Quirion, and K. Jhamandas Activity of spinal cannabinoid (CB-1) receptors in opioid withdrawal: a mechanism involving modulation of calcitonin gene-related peptide Soc Neurosci Abstr 2004
134. T. Trang, B. McNaull, R. Quirion, and K. Jhamandas Involvement of spinal lipoxygenase metabolites in hyperalgesia and opioid tolerance Eur J Pharmacol 491 2004 21 30
135. T. Trang, M. Sutak, R. Quirion, and K. Jhamandas The role of spinal neuropeptides and prostaglandins in opioid physical dependence Br J Pharmacol 136 2002 37 48
136. T. Trang, M. Sutak, R. Quirion, and K. Jhamandas Spinal administration of lipoxygenase inhibitors suppresses behavioural and neurochemical manifestations of naloxone-precipitated opioid withdrawal Br J Pharmacol 140 2003 295 304
137. K.A. Trujillo, and H. Akil Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801 Science 251 1991 85 87
138. 2+ entry Brain Res 425 1987 101 105
139. D. van Rossum, U.K. Hanisch, and R. Quirion Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors Neurosci Biobehav Rev 21 1997 649 678
140. T.W. Vanderah, L.R. Gardell, S.E. Burgess, M. Ibrahim, A. Dogrul, and C.M. Zhong Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance J Neurosci 20 2000 7074 7079
141. M.R. Vasko Prostaglandin-induced neuropeptide release from spinal cord Prog Brain Res 104 1995 367 380
142. M.R. Vasko, W.B. Campbell, and K.J. Waite Prostaglandin E2 enhances bradykinin-stimulated release of neuropeptides from rat sensory neurons in culture J Neurosci 14 1994 4987 4997
143. C.L. Walters, B.C. Wang, M. Godfrey, D. Sun, C.D. Funk, and J.A. Blendy Augmented responses to morphine and cocaine in mice with a 12-lipoxygenase gene disruption Psychopharmacology (Berl) 170 2003 124 131
144. S.P. Welch, P.P. Bass, K.G. Olson, and G. Pugh Morphine-induced modulation of calcitonin gene-related peptide levels Pharmacol Biochem Behav 43 1992 1107 1116
145. S.P. Welch, and D.L. Stevens Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice J Pharmacol Exp Ther 262 1992 10 18
146. H.L. Willingale, N.J. Gardiner, N. McLymont, S. Giblett, and B.D. Grubb Prostanoids synthesized by cyclo-oxygenase isoforms in rat spinal cord and their contribution to the development of neuronal hyperexcitability Br J Pharmacol 122 1997 1593 1604
147. R.I. Wilson, G. Kunos, and R.A. Nicoll Presynaptic specificity of endocannabinoid signaling in the hippocampus Neuron 31 2001 453 462
148. R.I. Wilson, and R.A. Nicoll Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses Nature 410 2001 588 592
149. C.S. Wong, M.M. Hsu, R. Chou, Y.Y. Chou, and C.S. Tung Intrathecal cyclooxygenase inhibitor administration attenuates morphine antinociceptive tolerance in rats Br J Anaesth 85 2000 747 751
150. T.L. Yaksh, T.M. Jessell, R. Gamse, A.W. Mudge, and S.E. Leeman Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo Nature 286 1980 155 157
151. Z. Ye, S.J. Wimalawansa, and K.N. Westlund Receptor for calcitonin gene-related peptide: localization in the dorsal and ventral spinal cord Neuroscience 92 1999 1389 1397
152. 8-37 increases the latency to withdrawal responses in rats Brain Res 653 1994 223 230
153. M. Zubrzycka, A. Janecka, W. Koziolkiewicz, and W.Z. Traczyk Inhibition of tongue reflex in rats by tooth pulp stimulation during cerebral ventricle perfusion with (6-11) substance P analogs Brain Res 753 1997 128 132